BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18385520)

  • 21. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
    Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
    Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor in physiology and infectious diseases.
    Imamura R; Matsumoto K
    Cytokine; 2017 Oct; 98():97-106. PubMed ID: 28094206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
    Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC
    Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
    Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat.
    Hu Z; Evarts RP; Fujio K; Marsden ER; Thorgeirsson SS
    Am J Pathol; 1993 Jun; 142(6):1823-30. PubMed ID: 8506951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor modulates in vitro survival and proliferation of germ cells during postnatal testis development.
    Catizone A; Ricci G; Del Bravo J; Galdieri M
    J Endocrinol; 2006 Apr; 189(1):137-46. PubMed ID: 16614388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple roles for hepatocyte growth factor in sympathetic neuron development.
    Maina F; Hilton MC; Andres R; Wyatt S; Klein R; Davies AM
    Neuron; 1998 May; 20(5):835-46. PubMed ID: 9620689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes.
    Beilmann M; Odenthal M; Jung W; Vande Woude GF; Dienes HP; Schirmacher P
    Blood; 1997 Dec; 90(11):4450-8. PubMed ID: 9373255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
    Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
    Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
    Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
    Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
    J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression.
    Liu Y; Centracchio JN; Lin L; Sun AM; Dworkin LD
    Exp Cell Res; 1998 Jul; 242(1):174-85. PubMed ID: 9665815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
    Kaldenbach M; Giebeler A; Tschaharganeh DF; Erschfeld S; Wasmuth HE; Dolle L; Floege J; Trautwein C; Streetz KL
    Gut; 2012 Aug; 61(8):1209-18. PubMed ID: 22287599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
    To CT; Tsao MS
    Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
    Huang X; Gan G; Wang X; Xu T; Xie W
    Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 Expression.
    Nishikoba N; Kumagai K; Kanmura S; Nakamura Y; Ono M; Eguchi H; Kamibayashiyama T; Oda K; Mawatari S; Tanoue S; Hashimoto S; Tsubouchi H; Ido A
    Front Immunol; 2020; 11():2135. PubMed ID: 32983173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.